Signaling Pathways - eIF4F - GSK-3 - KDR - FLT3
清除全部
- B1536 AZD10801 CitationTarget: GSK-3Summary: GSK3β抑制剂
- B1404 DCC-2036 (Rebastinib)Target: FLT3|Bcr-Abl|Tie-2|KDRSummary: Bcr-Abl抑制剂
- B3277 AMG 925Target: Cyclin-Dependent Kinases|FLT3Summary: FLT3/CDK4抑制剂
- A8616 A-674563Target: Cyclin-Dependent Kinases|Akt|GSK-3|ERK|PKC|PKA|RSKSummary: Akt1 / PKA / CDK2的强效选择性抑制剂
- A8396 CHIR-99021 (CT99021) HClTarget: GSK-3Summary: GSK-3α/β抑制剂
- A8395 CHIR-98014Target: GSK-3Summary: GSK-3β抑制剂
- A8394 CHIR-124Target: FLT3|GSK-3|Chk|PDGFRSummary: Chk1抑制剂
- A8476 MK-2461Target: FLT3|PDGFR|MET|RonSummary: C-Met(野生型/突变型)抑制剂
- A8307 Crenolanib (CP-868596)1 Citation中文名: 克莱拉尼Target: FLT3|PDGFRSummary: PDGFR-β有效的选择性抑制剂
- A5793 Quizartinib (AC220)中文名: 奎扎替尼Target: FLT3Summary: FLT3抑制剂